Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,904,472
+$3,650,457 QoQ
Shares Held
425,644
-28.2% QoQ
Ownership
0.294%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Derivatives in TNGX
reported options exposure · as of Jun 30, 2025CallValue
$230,400
CallShares
45,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. TNGX ranks #118 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in TNGX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,904,472 | 425,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,254,015 | 593,004 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,881,368 | 1,295,401 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $230,400 | 45,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $9,074,196 | 1,772,304 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,015,176 | 1,470,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $771,406 | 249,646 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $127,936 | 14,911 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $151,574 | 19,090 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,916,124 | 294,558 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $1,027,779 | 309,572 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $782,743 | 198,163 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $211,808 | 29,215 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $743,935 | 205,507 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $595,930 | 131,552 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,679,999 | 485,488 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||